Physician profile
Shannon Clay
NPI 1265994362
$62,714.97
in general payments reported to CMS, 2019-2025
16 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.02 · 2021: $17.61 · 2022: $284 · 2023: $466 · 2024: $802 · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $61K · Food and Beverage: $1,482 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $60,726.00 |
| Food and Beverage | $1,481.68 |
| Education | $182.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,732.88 | 2022-2025 | Resolute Onyx, Micra |
| Boston Scientific Corporation | $25,000.00 | 2025 | General - Structural Heart |
| Abbott Laboratories | $3,547.81 | 2025 | Xience V, Xience Skypoint |
| Novartis Pharmaceuticals Corporation | $399.09 | 2024 | |
| Irhythm Technologies, INC. | $158.26 | 2023-2024 | Zio Xt Patch, Zio At Patch |
| Chiesi USA, INC. | $140.43 | 2022-2023 | Kengreal |
| Pfizer INC. | $120.59 | 2024 | |
| Janssen Pharmaceuticals, INC | $119.97 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $98.27 | 2023 | Camzyos |
| Amgen INC. | $98.14 | 2024 | Repatha |
| Abbvie INC. | $83.83 | 2022 | |
| Abiomed | $33.27 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $17.61 | 2021 | |
| Gilead Sciences, INC. | $15.58 | 2022 | |
| Csl Behring | $11.67 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Clay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.